The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FGFR pathway genetic aberrations in cholangiocarcinoma: Demographics and experience with targeted therapy.
 
Apurva Jain
No Relationships to Disclose
 
Rachna T. Shroff
Stock and Other Ownership Interests - Celgene
Consulting or Advisory Role - Celgene; Clovis Oncology
Research Funding - Celgene; Lilly
Travel, Accommodations, Expenses - Celgene; Clovis Oncology
 
Robin Kate Kelley
Consulting or Advisory Role - Lilly
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Exelixis (Inst); Lilly (Inst); Novartis (Inst); Regeneron (Inst); Sanofi (Inst); Tekmira (Inst)
 
Ahmed Omar Kaseb
No Relationships to Disclose
 
Ying Wang
No Relationships to Disclose
 
Reham Abdel-Wahab
No Relationships to Disclose
 
Daniel H. Ahn
Consulting or Advisory Role - Celltrion (I)
 
Andrea Grace Bocobo
No Relationships to Disclose
 
Funda Meric-Bernstam
Honoraria - Genentech; Roche
Consulting or Advisory Role - Celgene; Genentech; Inflection Biosciences; Novartis; Roche
Research Funding - Aileron Therapeutics; AstraZeneca; Bayer; Calithera Biosciences; CytomX Therapeutics; Debiopharm Group; Genentech; Novartis; PUMA Biotechnology; Taiho Pharmaceutical; Verastem
 
Randi Isaacs
Employment - Novartis
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Lilly; NCCN; Pfizer; Regeneron; Research to Practice; Sanofi; Sirtex Medical; Taiho Pharmaceutical
Other Relationship - Exelixis; Polaris
 
Milind M. Javle
No Relationships to Disclose